Nuvation Bio Inc. (NUVB)
NYSE: NUVB · IEX Real-Time Price · USD
2.580
-0.110 (-4.09%)
Apr 18, 2024, 4:00 PM EDT - Market closed

Nuvation Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023202220212020
Market Capitalization
5633314191,851216
Market Cap Growth
--21.16%-77.35%757.28%-
Enterprise Value
-45-277-2371,0890
PE Ratio
-4.36-4.36-4.02-21.31-5.18
PB Ratio
0.930.550.642.481.00
P/FCF Ratio
-4.86-4.86-4.35-27.04-5.89
P/OCF Ratio
-4.86-4.86-4.36-27.15-5.91
EV/EBITDA Ratio
3.663.662.29-12.590.00
EV/EBIT Ratio
3.653.652.28-12.540.00
EV/FCF Ratio
4.064.062.46-15.90-0.01
Debt / Equity Ratio
0.010.010.010.00-
Debt / EBITDA Ratio
-0.05-0.05-0.04-0.04-
Debt / FCF Ratio
-0.06-0.06-0.04-0.04-
Quick Ratio
43.7443.7450.2345.2232.93
Current Ratio
44.1144.1150.7045.6233.69
Return on Equity (ROE)
-12.20%-12.20%-15.20%-11.20%-43.60%
Return on Assets (ROA)
-11.90%-11.90%-14.70%-10.80%-24.30%
Return on Capital (ROIC)
-16.39%-16.39%-18.16%-12.46%-20.25%
Earnings Yield
-13.47%-22.93%-24.85%-4.69%-19.29%
FCF Yield
-12.10%-20.58%-23.01%-3.70%-16.98%
Buyback Yield / Dilution
-1.00%-1.00%-9.52%-102.90%52.81%
Total Shareholder Return
-1.00%-1.00%-9.52%-102.90%52.81%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).